Cargando…
Development of Triantennary N-Acetylgalactosamine Conjugates as Degraders for Extracellular Proteins
[Image: see text] Targeted protein degradation (TPD) technology has drawn significant attention from researchers in both academia and industry. It is rapidly evolved as a new therapeutic modality and also a useful chemical tool in selectively depleting various protein targets. As most efforts focus...
Autores principales: | Zhou, Yaxian, Teng, Peng, Montgomery, Nathan T., Li, Xiaolei, Tang, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006166/ https://www.ncbi.nlm.nih.gov/pubmed/33791431 http://dx.doi.org/10.1021/acscentsci.1c00146 |
Ejemplares similares
-
Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation
por: Cui, Hao, et al.
Publicado: (2021) -
The therapeutic prospects of N-acetylgalactosamine-siRNA conjugates
por: Zhang, Lei, et al.
Publicado: (2022) -
Targeting Angiotensinogen With N-Acetylgalactosamine–Conjugated Small Interfering RNA to Reduce Blood Pressure
por: Ye, Dien, et al.
Publicado: (2023) -
Plasma Pharmacokinetics of N-Acetylgalactosamine-Conjugated Small-Interfering Ribonucleic Acids (GalNAc-Conjugated siRNAs)
por: Sten, Sebastian, et al.
Publicado: (2023) -
Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice
por: Prakash, Thazha P., et al.
Publicado: (2014)